Brattleboro Retreat

Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis

Retrieved on: 
Tuesday, October 17, 2023
Investment, Food, Lupus nephritis, Division, Death, Cytarabine, NKG2D, Risk, Rituximab, IND, Safety, University, AML, Conference call, AID, Brattleboro Retreat, Autoimmune disease, Dialysis, FDA, B-cell lymphoma, Workforce, Department of Medicine – University of Pamplona, Lupus, ET, CAR, Immune system, Patient, End organ damage, Rheumatic Disease Clinics of North America, LN, Kidney disease, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, SAN, MRD, NK, University of Massachusetts Chan Medical School, Parikh, Conference, Investigational New Drug, SLE, NHL, Pharmaceutical industry, Vaccine, Cryptocurrency, Nursing, LD, Rheumatology, Medicine

(1)

Key Points: 
  • (1)
    The multi-center, open label, dose escalation clinical trial will assess the safety and clinical activity of NKX019 in patients with refractory LN.
  • “The clearance of Nkarta’s IND for NKX019 in lupus nephritis is an important achievement for Nkarta, and we feel NK cell therapy is ideally suited for the treatment of autoimmune disease,” said Paul J. Hastings, President and CEO of Nkarta.
  • Nkarta announced today the opening of a new cohort in its Phase 1 study of NKX019 in r/r NHL.
  • Nkarta management will discuss its program in autoimmune disease and other corporate updates on Tuesday, October 17, at 8:00 a.m.

Inovalon Expands Revenue Cycle Data Analytics Software to Support All EDI Clearinghouses for Healthcare Providers

Retrieved on: 
Wednesday, April 19, 2023
Intelligence, Psychiatry, Medicaid, EDI, Health, RCM, Ageing, Brattleboro Retreat, EHR, Revenue cycle management, Data, Conference, Health insurance, Inovalon, Medicare

BOWIE, Md., April 19, 2023 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced that RCM Intelligence , a revenue cycle management (RCM) solution providing integrated analytics and data visualization capabilities, will now be compatible with all electronic data interchange (EDI) claims clearinghouses, connecting to commercial, Medicare, and Medicaid payers.

Key Points: 
  • BOWIE, Md., April 19, 2023 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced that RCM Intelligence , a revenue cycle management (RCM) solution providing integrated analytics and data visualization capabilities, will now be compatible with all electronic data interchange (EDI) claims clearinghouses, connecting to commercial, Medicare, and Medicaid payers.
  • Leveraging Inovalon’s advanced analytics, RCM Intelligence seamlessly operationalizes raw claims data to deliver real-time insights that improve cash flow, profitability, and productivity for healthcare providers without having to compromise performance based on which EDI clearinghouses they may be using.
  • These insights include payer performance trends, claims corrections, cash projections, time-to-file rates, turnaround times, and denial percentages.
  • Traditional RCM reporting is labor-intensive, inefficient, and generally manual, increasing the likelihood of errors and denials from health plans.